Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.05.2011 | Case report

Trastuzumab

Congestive heart failure: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Tanz R, Mahfoud T, Bazine A, Khmamouch R, Bensouda Y, Ismaili N, Benjaafar N, El Gueddari BK, Ichou M, Errihani H.Cardiac safety of trastuzumab in adjuvant: A review across 53 observations. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 40: 144-148, No. 2, Apr 2011. Available from: URL: http://dx.doi.org/10.1016/j.jgyn.2010.12.003 - Morocco Tanz R, Mahfoud T, Bazine A, Khmamouch R, Bensouda Y, Ismaili N, Benjaafar N, El Gueddari BK, Ichou M, Errihani H.Cardiac safety of trastuzumab in adjuvant: A review across 53 observations. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 40: 144-148, No. 2, Apr 2011. Available from: URL: http://​dx.​doi.​org/​10.​1016/​j.​jgyn.​2010.​12.​003 - Morocco
Metadaten
Titel
Trastuzumab
Congestive heart failure: 3 case reports
Publikationsdatum
01.05.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113510-00154

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Aciclovir

Case report

Rituximab

Case report

Clarithromycin

Case report

BCG

Case report

Sitaxentan

Case report

Promelase